Target intelligence / Profile preview

Cysteine-rich C-terminal protein 1 (CRCT1)

Target
CRCT1
Molecular classification
Other
01

Overview

Cysteine-rich C-terminal protein 1 (CRCT1), encoded by the CRCT1 gene (previously known as C1orf42 or NICE1), is a human protein of unknown function[2][3][5][7]. The gene is located on chromosome 1, and its expression has been detected in a range of tissues[4]. To date, there is no experimental evidence supporting a role for this protein as an enzyme, receptor, transporter, or signaling molecule. The most notable associations with disease are indirect: some bioinformatics and clinical databases have linked CRCT1 to rare tumor types, such as salivary gland mucoepidermoid carcinoma and esophageal adenosquamous carcinoma, but no mechanistic or functional studies have established its involvement in these diseases[3]. There are no known drugs that interact with CRCT1, and it is not currently used as a biomarker or therapeutic target. Further research is required to elucidate its molecular function, biological pathways, and potential clinical relevance.

Other names
C1orf42NICE1NICE-1protein NICE-1cysteine-rich C-terminal protein 1
02

Disease associations

Salivary gland mucoepidermoid carcinomaEsophageal adenosquamous carcinoma

Beyond the preview

Go deeper on Cysteine-rich C-terminal protein 1 (CRCT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cysteine-rich C-terminal protein 1 (CRCT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call